article · Journal of Biomolecular Structure and Dynamics
The abstract on record is too brief for a reliable plain-language summary, so none has been generated.
as a promising dual CDK2/PIM1 inhibitor with potent anti-cancer activity and selectivity, paving the way for its further optimization and development as a lead molecule in cancer therapy.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1080/07391102.2025.2475233
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
